Skip to main content
. 2022 Sep 12;18(9):e1009921. doi: 10.1371/journal.pcbi.1009921

Fig 6. TAMC predicts changes in constitutive CTCF binding sites during ZGA.

Fig 6

(A) Schematic show CTCF knockdown prevents TAD formation during human ZGA. (B) Venn diagram shows the overlap between predicted constitutive CTCF binding sites in 2-cell and 8-cell embryos. (C) Metagene plots show aggregated cleavage profiles of predicted 2-cell specific (Group A), common (Group B) and 8-cell specific (Group C) in 2-cell and 8-cell embryos.